Freedom Capital Markets Maintains Buy Rating on Omada Health
Freedom Capital Markets maintained its Buy rating and $35.00 price target on Omada Health. The target implies 91.3% upside from the Oct. 13 close of $18.30.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.